Ralph Brinck-Heimke
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Study protocol: double-blind, randomized, prospective, placebo controlled parallel group phase II study to investigate the effect of glycerol phenylbutyrate (GPB) on neurofilament light chain (NfL) levels in patients with corticobasal syndrome (CBS).
Journal: Neurological research and practice
Published: March 11, 2026
Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT).
Journal: EClinicalMedicine
Published: May 05, 2025
Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets.
Journal: Pharmaceutics
Published: March 04, 2024
Tracking cell turnover in human brain using 15N-thymidine imaging mass spectrometry.
Journal: Frontiers in neuroscience
Published: August 08, 2023
Case Report: Local Treatment of a Leishmania tropica Infection in a Syrian Child with a Novel Filmogenic Preparation of Pharmaceutical Sodium Chlorite (LeiProtect®).
Journal: The American journal of tropical medicine and hygiene
Published: September 07, 2021
Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: September 29, 2015
Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility.
Journal: International journal of nanomedicine
Published: November 04, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026